Globus Medical Q2 2024 Adj. EPS $0.75 Beats $0.68 Estimate, Sales $629.700M Beat $615.345M Estimate
Author: Benzinga Newsdesk | August 06, 2024 04:16pm
Globus Medical (NYSE:
GMED) reported quarterly earnings of $0.75 per share which beat the analyst consensus estimate of $0.68 by 10.29 percent. The company reported quarterly sales of $629.700 million which beat the analyst consensus estimate of $615.345 million by 2.33 percent. This is a 115.94 percent increase over sales of $291.615 million the same period last year.
Posted In: GMED